ArthroLense completed an undisclosed funding round. The company is developing real-time, hologram-based navigation systems for surgical procedures. Initial product development will target unmet needs and opportunities in high-volume orthopedic procedures, including hip and knee arthroplasty.
Through 3D spatial mapping and proprietary multi-axis marker placards, ArthroLense technology allows physicians to visualize the effects and results of tissue cuts and preparatory procedures automatically, with no pre-op scans and no bone array placements.
ArthroLense will use the funds to support completion of its product design history file, embark on an initial FDA 510(k) regulatory filing and bolster the company’s intellectual property portfolio in advance of global commercialization.
“New medical technologies often add time to surgery and end up being complicated for the user and expensive for the institution,” said co-founder Dr. Russell Nevins. “But the ArthroLense system is engineered to integrate seamlessly with the current surgical flow in an intuitive and beneficial manner. And, by eliminating the typical touchscreen and foot pedal setup, we empower physician users to interact using gestures and voice commands, an ideal configuration for busy surgeons and particularly those operating at ambulatory surgical centers.”
ArthroLense completed an undisclosed funding round. The company is developing real-time, hologram-based navigation systems for surgical procedures. Initial product development will target unmet needs and opportunities in high-volume orthopedic procedures, including hip and knee arthroplasty.
Through 3D spatial mapping and proprietary...
ArthroLense completed an undisclosed funding round. The company is developing real-time, hologram-based navigation systems for surgical procedures. Initial product development will target unmet needs and opportunities in high-volume orthopedic procedures, including hip and knee arthroplasty.
Through 3D spatial mapping and proprietary multi-axis marker placards, ArthroLense technology allows physicians to visualize the effects and results of tissue cuts and preparatory procedures automatically, with no pre-op scans and no bone array placements.
ArthroLense will use the funds to support completion of its product design history file, embark on an initial FDA 510(k) regulatory filing and bolster the company’s intellectual property portfolio in advance of global commercialization.
“New medical technologies often add time to surgery and end up being complicated for the user and expensive for the institution,” said co-founder Dr. Russell Nevins. “But the ArthroLense system is engineered to integrate seamlessly with the current surgical flow in an intuitive and beneficial manner. And, by eliminating the typical touchscreen and foot pedal setup, we empower physician users to interact using gestures and voice commands, an ideal configuration for busy surgeons and particularly those operating at ambulatory surgical centers.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
